Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Journal Abstract

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.

Publication Date: 2024 Apr 18

Full Text Sources

Authors

Troels Yndigegn; Bertil Lindahl; Katarina Mars; Joakim Alfredsson; Jocelyne Benatar; Lisa Brandin; David Erlinge; Ola Hallen; Claes Held; Patrik Hjalmarsson; Pelle Johansson; Patric Karlström; Thomas Kellerth; Toomas Marandi; Annica Ravn-Fischer; Johan Sundström; Ollie Östlund; Robin Hofmann; Tomas Jernberg

Abstract

OBJECTIVE

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker-based diagnosis of myocardial infarction and treatment with percutaneous coronary intervention, antithrombotic agents, high-intensity statins, and renin-angiotensin-aldosterone system antagonists.

Source

The New England journal of medicine

Pub Types(s)

Journal Article

Language

English

PubMed ID

38587241